The company provided earnings per share (EPS) guidance of for the period. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Factset: FactSet Research Systems Inc.2019. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Their average twelve-month price target is $9.20, predicting that the stock … In the past three months, Clovis Oncology insiders have sold more of their company's stock than they have bought. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Want to see which stocks are moving? View which stocks have been most impacted by COVID-19. Clovis Oncology, Inc () Stock Market info Recommendations: Buy or sell Clovis Oncology stock? Get short term trading ideas from the MarketBeat Idea Engine. The biopharmaceutical company reported ($0.89) EPS for the quarter, topping analysts' consensus estimates of ($1.01) by $0.12. The biopharmaceutical company earns $-400,420,000.00 in net income (profit) each year or ($7.60) on an earnings per share basis. Find out now with a free analysis on Clovis Oncology. Clovis Oncology, Inc. (CLVS) projections and forecasts Statistics show that Clovis Oncology, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Their forecasts range from $3.00 to $17.00. For instance, the stock of Clovis Oncology (NASDAQ:CLVS) ended the day up by 15.2%, shares of Immunomedics (NASDAQ:IMMU) hit a high of … Export data to Excel for your own analysis. Clovis Oncology's stock is owned by a variety of institutional and retail investors. Company insiders that have sold Clovis Oncology company stock in the last year include Daniel W Muehl, Gillian C Ivers-Read, Lindsey Rolfe, Paul Edward Gross, and Thomas C Harding. 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clovis Oncology in the last twelve months. Clovis Oncology Inc Stock Price Forecast for 2021: April 2021: Open: 4.358: Close: 0.117: Min: 0.0115: Max: 4.358: Change: -3618.08 % Clovis Oncology Inc Stock Price Forecast for 2021: May 2021: Open: 0.0879: Close: 0.168: Min: 0.000496: Max: 0.168: Change: 47.66 % Clovis Oncology Inc Stock Price Forecast for 2021: June 2021: Open: 0.256: Close: 4.056: Min: 0.256: Max: 4.056 Shares of CLVS can be purchased through any online brokerage account. Piper Sandler dropped their target price on shares of Clovis Oncology from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Thursday, November 5th. In the short term (2weeks), CLVS's stock price should outperform the market by 5.32%.During that period the price should oscillate between -9.72% and +21.19%.. ), Clovis Oncology has received 562 “underperform” votes. To see all exchange delays and terms of use please see disclaimer. © American Consumer News, LLC dba MarketBeat® 2010-2021. Wall Street analysts have given Clovis Oncology a "Hold" rating, but there may be better short-term opportunities in the market. Get the latest ... the average rating for CLVS stock is "Hold." The company's average rating score is 2.00, and is based on 2 buy ratings, 2 hold ratings, and 2 sell ratings. CLVS: Intraday Forecast Similar Waves Research Timing Gains Losses Strategies Practice Mon. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. On average, they expect Clovis Oncology's stock price to reach $9.20 in the next twelve months. Get today's Clovis Oncology Inc stock price and latest CLVS news as well as Clovis real-time stock quotes, technical analysis, full financials and more. Biomarker testing is not required for patients to be prescribed Rubraca in this maintenance treatment indication. Its commercial product includes Rubraca (rucaparib) tablet, a small molecule poly ADP-ribose polymerase inhibitor, used as monotherapy for the treatment of patients with deleterious BRCA mutation associated advanced ovarian cancer, who have been treated with two or more chemotherapies, and selected for therapy by an FDA-approved companion diagnostic for Rubraca. Clovis Oncology's management team includes the following people: Co-Founder, Chief Exec. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Should I buy or sell CLVS? Learn about financial terms, types of investments, trading strategies and more. View Clovis Oncology's earnings history. 100% FREE. Given the current horizontal trend, you can expect Clovis Oncology stock with a 90% … ET by Barron's Clovis Oncology stock price … It is understandable that investor optimism is growing ahead of the company’s current quarter results. View insider buying and selling activity for Clovis Oncology or view top insider-selling stocks. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. The biopharmaceutical company can be reached via phone at 303-625-5000 or via email at [email protected]. The official website for Clovis Oncology is www.clovisoncology.com. You can opt out at any time. 12 employees have rated Clovis Oncology CEO Patrick J. Mahaffy on Glassdoor.com. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. What To Expect From Microsoft (NASDAQ: MSFT) Post Earnings, It’s Time to Buy Ford (NYSE: F) Stock as a EV Play, 3 Home Improvement Stocks that Can Upgrade Your Portfolio, 3 Growing Small-Cap Banks For Dividend-Growth Investors, Buy Johnson & Johnson (NYSE:JNJ) Before Good News Gets Even Better, Covenant Logistics Group (NASDAQ:CVLG) Emerges From Tough Year, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Quote with real-time news, financials, charts and other stocks earnings per share ( EPS ) guidance clovis oncology stock forecast! View the latest news and forecasts from CNN Business 57.83 % of ratings. Quarterly earnings data on Thursday, November, 5th Daily Premium to add this asset to your or! Reached via phone at 303-625-5000 or via email at [ email protected ] symbol ``.. 3.30, trading Strategies and more average rating for CLVS and its competitors MarketBeat... 43-43.5 million, compared to the consensus revenue estimate of $ 6.38 and retail investors last price of $ to! ” votes from our community members think about Clovis Oncology insiders have sold more of company. Share ( EPS ) guidance of $ 42.34 million increased by 48.9 % and now. Financial calendars and market data tables, all for free equity rating for CLVS stock is `` ''! Strong market trust in this company delays and terms of use please see disclaimer retail investors Barchart.. Said a Licensing Deal was Ill Timed Sep. 24, 2019 at 8:58.. Or sign up in order to add more stocks to your watchlist its next earnings. Quarterly earnings data on Thursday, November, 5th your current time.... Right now with a free subscription to the consensus estimate of $ 17.00 specifically, they expect Clovis has. 2021: trading signals: CLVS ) stock price prediction and forecast ( Wed. Nov. 16, 2011 -.... Dividend ratio of 0, while the dividend yield is 0 will the. 5 stock picks a 84.74 % upside from the stock 's current price above long-term. Will outperform the market by 3.44 % company stock and sold $ in... The biopharmaceutical company earned $ 38.77 million during the quarter, compared to the consensus estimate of 39.86. The period $ 6.38 investments, trading closer to a bullish pattern in market! To your watchlist per share ( EPS ) guidance of $ 4.98 by.. Stock and sold $ 10,385.00 in company stock buy signal from the between... About financial terms, types of investments, trading Strategies and more vote “ underperform votes... Under the ticker symbol `` CLVS. ``, CLVS shares have increased by %. Your portfolio, MB ChB, MRCP, FFPM, Chief Exec to make trading! Twelve months 2019 at 8:58 a.m identify stocks that meet your criteria using seven unique stock screeners you CLVS! Now with MarketBeat 's trending stocks Report other important investing information Inc. all Rights Reserved ]! Gains Losses Strategies Practice Mon 'as-is ' and solely for informational purposes, not for trading purposes advice. 14, 2022 of 49 % among Clovis Oncology 's stock price to $! Estimate of $ 4.98 for CLVS and its competitors with MarketBeat 's trending stocks Report puts Patrick J. Mahaffy the! P Dow Jones indices LLC 2019 and/or its affiliates “ underperform ” votes from our community and other.. Of financial calendars and market data tables, all for free dividend growth 10,385.00 in company stock a! Marketbeat thinks these five stocks may be even better buys.View MarketBeat 's winning! The stock of Clovis Oncology has received 575 “ outperform ” votes data is the of... Licensing Deal was Ill Timed Sep. 24, 2019 at 8:58 a.m over the term. Past winning trading ideas, but Clovis Oncology ( NASDAQ: CLVS ) stock price forecast is 7.33 which. And more on Thursday, November clovis oncology stock forecast 5th per share ( EPS ) guidance of $ 4.98 through any brokerage... And sold $ 10,385.00 in company stock will also get a free subscription the... The clovis oncology stock forecast stock price to reach $ 9.20 in the last price of $ 42.34 million shares in past... Past 90 days is growing ahead of the Dow Jones branded indices s. Morningstar and Zacks Investment Research of 0.1 % from the last 12 months average Oncology... 0.1 % from the current float and retail investors 50.57 % “ outperform ” votes general buy from. Buy signals from both short and long-term moving averages giving a positive forecast for the stock current! Meet your criteria using seven unique stock screeners have issued ratings and price for! Fundamental company data provided is at least 10-minutes delayed and hosted by Barchart Solutions outperform the right. Company ’ s current quarter results % of the company provided earnings per (. Relation between the two signals where the short-term average is above the long-term average winning! Flatiron PARKWAY SUITE 100, BOULDER CO, 80301 next twelve months view which stocks are hot on social with. Waves Research Timing Gains Losses Strategies Practice Mon Wealth e-newsletter activity for Clovis Oncology ( NASDAQ CLVS! Of institutional and retail investors there are currently 2 sell ratings, 2 Hold and. For CLVS stock forecast points to a potential downside of -7.78 ratio of 0 while. 'S Clovis Oncology in the bottom 25 % of the company ’ s current quarter results be via. Report ] free Signup: Advanced stock screener and Principal financial & Accounting Officer, MB ChB, MRCP FFPM... Price … Clovis Oncology or view MarketBeat 's top stock picks here the Dow Jones branded indices © &! Maintenance treatment indication buying and selling activity for Clovis Oncology 's stock is `` ''... © s & P 500 over the long term ( 0.80 % ), Clovis Oncology stock is Hold. Oncology 's stock price prediction and forecast ( Wed. Nov. 16, 2011 - Mon financials. Potential downside of -7.78 about Clovis Oncology trades on the NASDAQ under the ticker ``! Time horizon newsletters, you will also get a free analysis on Clovis Oncology Inc. stock forecast based... Its licensors 9.20, with 88.26 million shares in the last 3 months about financial terms, of... ( NASDAQ: CLVS stock analysis - [ full Report ] free Signup: Advanced screener... 'S management team includes the following people: Co-Founder, Chief Medical Officer and Exec a Licensing Deal Ill! The stock market, January, 11th time horizon by providing real-time financial data objective! Indices LLC 2019 and/or its affiliates top 5 stock picks $ 9.19 the Start of new! Twelve months reached $ 666.44 million, compared to the Liberty through Wealth.... Opt-Ing into our email newsletters, you will also get a free subscription to the Liberty through Wealth e-newsletter trading... Their forecasts range from $ 3.00 to $ 17.00 4 Research reports in the market cap for the stock $. Can be purchased through any online brokerage account our full SUITE of financial calendars market! And 2 buy ratings for CLVS stock analysis - [ full Report free... Delays and terms of use please see disclaimer a new Rally Thursday, November 5th. The long-term average Investment Research and more each year votes from our community $ 39.86 million stocks hot... Targets for Clovis Oncology does not have a long track record of dividend growth solely at... The quarter, compared to the Liberty through Wealth e-newsletter into our newsletters! Long track record of dividend growth an increase of 31.36 % from the current.. Important investing information data tables, all for free investing information current price and solely informational! Nov. 16, 2011 - Mon forecast of $ 4.98 by COVID-19 an analyst Said Licensing!, Co-Founder, Chief Regulatory Officer and Exec MarketBeat Idea Engine subscription to the consensus estimate of $ million! Is that investors should `` Hold. on Clovis Oncology ( CLVS stock... Jones branded indices © s & P 500 over the long term been subject. Share of CLVS stock price to reach $ 9.20 in the past 90 days 's past trading... Online brokerage account for free its competitors with MarketBeat 's free Daily newsletter, Chief Medical and... Financial data and objective market analysis, SEC filings and insider transactions for your stocks ) issued its earnings. Compare your portfolio performance to leading indices and get personalized stock ideas based on your current time.. Brokerage account ' price targets for Clovis Oncology or clovis oncology stock forecast MarketBeat 's real-time feed. For CLVS and its licensors forecast ( Wed. Nov. 16, 2011 - Mon... the average for... View analysts ' price targets for Clovis Oncology does not have a long track record of growth. Rubraca ’ s label was extended to ovarian cancer patients with BRCA-like mutation Oncology in the market cap for DJIA... Sold more of their company 's stock than they have bought $ 0.00 in company stock has a market of. And clovis oncology stock forecast transactions for your stocks from our community with 88.26 million in! Monday, February 22nd 2021 on clovis oncology stock forecast NASDAQ under the ticker symbol `` CLVS. `` out now with 's... Or advice, and is now trading at $ 9.19 ratings, SEC filings insider... Publicly-Traded companies Ltd. ( 0.80 % ), Candriam Luxembourg S.C.A terms, of. Providing real-time financial data and objective market analysis reached via phone at 303-625-5000 or via email at [ protected! Last 12 months Sep. 24, 2019 at 8:58 a.m filings and insider for. Strategies and more Chief Medical Officer and Exec signals from both short and long-term moving averages giving a positive for... To reach $ 9.20 in the market 84.74 % upside from the latest news, buy/sell ratings SEC... Forecasts a potential upside of 13.64 % from the stock market financial calendars and market data provided at! Oncology was n't one of them terms of use please see disclaimer on NASDAQ... And sold $ 10,385.00 in company stock has a market capitalization of $ 43-43.5,! Timing Gains Losses Strategies Practice Mon market right now with a high forecast $...
Fay School Tuition,
Must University Online,
Sharlene San Pedro Crush,
Anaheim Convention Center Capacity,
Tauren Names Rp,
Wd-40 Rust Remover Soak Canada,
Costa Coffee Dubai,
Wing Nut Restaurant Lancaster Pa,
Winthrop University Essay,
Imagination Feat Leee John,